Related Experiment Video
Updated: Mar 31, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Four-factor prothrombin complex concentrates in paediatric patients - a retrospective case series
T Noga1,2, A A K Bruce3,2, H Blain4
1University of Alberta Hospital, Edmonton, AB, Canada.
Four-factor prothrombin complex concentrates (PCCs) effectively reverse vitamin K antagonists in children, showing safety and efficacy similar to adults. This study reviewed PCC use in pediatric patients over five years.
Area of Science:
- Hematology
- Pediatric Medicine
- Pharmacology
Background:
- Four-factor prothrombin complex concentrates (PCCs) are plasma-derived products containing coagulation factors II, VII, IX, and X.
- PCCs are approved for bleeding or prophylaxis in acquired factor deficiency, often linked to vitamin K antagonist (VKA) use.
- Limited data exists on PCC efficacy and safety in pediatric populations compared to adults.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Venous Thrombosis III: Interprofessional Care
EDTA: Auxiliary Complexing Reagents
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pharmacokinetics in Pediatric Patients: Drug Excretion

